Table 3.
Author(s), year, country, pandemic or threat referred to | Scale or concept measured | Underlying theoretical framework | Number of items | Item response format | Language & time to complete the questionnaire | Validity and reliability |
---|---|---|---|---|---|---|
Yonge et al., 2007, Yonge et al., 2010; Rosychuk et al., 2008, Canada, avian influenza | General knowledge about avian flu | Not reported | 5 items | Five-point Likert scale (1 = very unlikely, 5 = very likely) | English; time not reported | Not reported |
Risk perception | 4 items | |||||
Willingness to volunteer | 11 items | |||||
Treatment | Not reported | |||||
Allocation of resources | Not reported | |||||
Wu et al., 2009, Taiwan, SARS | Knowledge Scale about standard and additional infection control precautions | Items formulated and established based on CDC guidelines; Scales adapted from prior studies (Calabro et al., 1998; Chan et al., 2002) |
15 items | 11 true/false and 4 multiple-choice questions | Not reported; 20–35 min | Reliability: 0.79 |
Application Scale: includes three different real-world clinical scenarios followed by statements based on CDC guidelines | 13 statements | Yes/No | Not amenable to psychometric testing | |||
Confidence Scale | 8 statements | Yes/No | Reliability: 0.86 | |||
Stirling et al., 2015, Saudi Arabia, MERS | Knowledge about MERS | Based on Ministry of Health | Not reported | Not reported | English and Arabic; time not reported | Not reported |
Lessons learned about MERS | Not reported | Not reported | ||||
Chilton et al., 2016, USA, EVD | Survey of Nursing Student Self-reported Knowledge of EVD | Based on CDC guidelines | 1 item | Rated poor (0) to excellent (4) | English; time not reported | An exploratory factor analysis of the seven-item willingness-to-treat scale revealed a single-factor solution. Reliability: Cronbach's alpha of 0.92 |
Willingness to Treat and Perceptions of Duty to Treat | 7 items | Three items positively framed: How likely are you to take an action, rated from 0 (very unlikely) to 4 (very likely). Four items negatively framed: How likely are you to refuse to take a certain action, rated from 0 (very unlikely) to 4 (very likely). | ||||
Choi & Kim, 2016 Kim & Choi, 2016, South Korea, MERS |
Knowledge about MERS-CoV: cause of MERS, test, treatment, prevention | MERS-related knowledge based on response guidelines of the CDC and the Korea Centres for Disease Control and Prevention and on the questions used to survey health care workers' knowledge in a previous study (Khan et al., 2014) | 16 items | Likert scale from 1 (not relevant) to 4 (very relevant) | Not reported | Knowledge: reliability (Kuder-Richardson 20): 0.79 Attitude: reliability (Cronbach's alpha) 0.79 Preventive behaviour: reliability (Cronbach's alpha) 0.85 |
Attitude towards MERS-CoV | 9 items | Likert scale from 1 (Not at all) to 5 (Absolutely yes) | ||||
Perceived risk of acquiring MERS-CoV | 1 item | Descriptive 5-point scale from 1 (Not at all) to 5 (Absolutely yes) | ||||
Preventive behaviour against MERS-CoV: use of public places, avoidance of people coughing, cleaning and disinfection, hand washing | 10 items | Each item could be answered as “Performed” (1) or “Not performed”/“Not applicable” (0) | ||||
Ferranti et al., 2016, USA, EVD | Knowledge retention | According to CDC guidelines | 13 items | Correct/Incorrect or True/False | English; 15 min | Not reported |
Concerns about the risk of EVD: risk as a health care provider; risk as a resident | 2 items | Four ordinal categories (0 = not at all to 3 = extremely) | Cronbach's alpha coefficient of 0.865 | |||
Confidence in addressing EVD: confidence in discussing EVD with family, in answering questions about EVD transmission, in conveying a calm message about the general public's risk for EVD | 3 items | Not reported | Reliability: Cronbach's alpha of 0.905. | |||
Elrggal et al., 2018, Saudi Arabia, MERS |
Knowledge about MERS, including causes, sources of transmission, mortality, clinical manifestations, prevention strategies and risk groups for MERS | Structured questionnaire developed using the style and format of some of the questions used in two previous studies (Khan et al., 2014; Kharma et al., 2015) | 9 items | Three possible levels (yes, no, I don't know). A score of 1 was given for each correct answer. | English; time not reported | Authors state that the presentation and validity of the questionnaire were undertaken by experienced academic and senior pharmacy students. |
Sources of knowledge about MERS | 1 item | Open question | ||||
Attitudes and beliefs about MERS | 5 items | 5-point Likert scale (1 = strongly agree, 2 = agree, 3 = neutral, 4 = disagree and 5 = strongly disagree). | ||||
Patel et al., 2018, USA, EVD | Knowledge about EVD: transmission | Questionnaire similar to the one developed by Akram et al. for leishmaniasis and by Arief et al. for the Zika virus | 10 items | Yes/true, No/false, or unsure | English; 20–25 min | Not reported |
Knowledge about EVD: prevention | 16 items | 5-point Likert scale (1 = strongly agree; 5 = strongly disagree) | ||||
Etokidem et al., 2018, Nigeria, EVD | Sources of information about EVD | Not reported | 1 item | Open question | Not reported | Not reported |
Knowledge about EVD | 6 items | Open questions | ||||
Attitude towards people with EVD | 5 items | 1 open question and 4 dichotomous yes/no | ||||
Practice regarding EVD prevention | 11 items | Dichotomous yes/no | ||||
Escalera-Antezana et al., 2020, Bolivia and Colombia, COVID-19 | Knowledge about COVID-19 | Not reported | 5 items | Dichotomous correct/incorrect statement | Spanish; time not reported | Not reported |
Modi et al., 2020, India, COVID-19 | Knowledge and infection control | Adapted from the CDC guidelines | 17 items | Not reported | Not reported | Not reported |
CDC: Centers for Disease Control and Prevention, Atlanta, USA; COVID-19: Coronavirus disease 2019 caused by SARS-CoV-2; EVD: Ebola virus disease; MERS: Middle East respiratory syndrome; SARS: Severe acute respiratory syndrome.